✦ LIBER ✦

Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease

✍ Scribed by Lopez, Anthony; Mounier, Morgane; Bouvier, Anne-Marie; Carrat, Fabrice; Maynadié, Marc; Beaugerie, Laurent; Peyrin-Biroulet, Laurent

Book ID: 122159526
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 283 KB
Volume: 12
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2014.02.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Risk for Nonmelanoma Skin Canc

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

✍ Peyrin–Biroulet, Laurent; Khosrotehrani, Kiarash; Carrat, Fabrice; Bouvier, Anne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Patterns of Infection in Patients With M

Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

✍ Falantes, Jose F.; Calderón, Cristina; Márquez-Malaver, Francisco J.; Aguilar-Gu 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 291 KB

Relapsed and secondary disease drive the

Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome

✍ van de Peppel, R. J.; Dekkers, O. M.; von dem Borne, P. A.; de Boer, M. G. J. 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 341 KB

O-021 Patterns of infection in patients

O-021 Patterns of infection in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) receiving 5-azacitidine. Candidates for antifungal prophylaxis

✍ Falantes, J.; Calderón, C.; Márquez-Malaver, F.J.; Aguilar, M.; Martino, M.L.; G 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A comparison of low-dose cytarabine and

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

✍ Alan K. Burnett; Donald Milligan; Archie G. Prentice; Anthony H. Goldstone; Mary 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

Clinical Prognostic Factors for Survival

Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic Categories

✍ Falantes, Jose F.; Calderón, Cristina; Márquez Malaver, Francisco J.; Alonso, Do 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 498 KB